BTG Trademark

Trademark Overview


On Tuesday, October 27, 2009, a trademark application was filed for BTG with the United States Patent and Trademark Office. The USPTO has given the BTG trademark a serial number of 77858442. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, June 24, 2021. This trademark is owned by BTG International Limited. The BTG trademark is filed in the Chemical Products, Pharmaceutical Products, Medical Instrument Products, and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical and medicinal preparations and substances namely, vaccines and vaccine adjuvants, proteins, peptides, sera containing polyclonal antibodies and fragments thereof and polyclonal antibodies and fragments derived therefrom all for use in treating snake envenomation, overdose of toxic substances or sepsis; pharmaceutical preparations and substances for the treatment of thrombosis, [ inflammation, autoimmune disease and sleep disorders; dietetic foods adapted for medical use; ] vaccines; sera; polyclonal antibodies and fragments thereof for in vitro disease testing and for use in treating snake envenomation, overdose of toxic substances or sepsis; pharmaceutical preparations in the form of foams or for use in producing foams for use in sclerotherapy, phlebology, angiology and proctology, for treatment of oesophageal varices, hydroceles, in sterilisation treatment or for treatment of varicose veins or arteriovenous malformations; chemical reagents for medical or veterinary pur...

[ Chemicals used in science; chemicals for clinical research use; diagnostic reagents and substances for clinical and medical laboratory use; diagnostic reagents and substances for clinical and medical laboratory in vitro research use; polyclonal antibodies and fragments thereof for clinical research use; diagnostic reagents and substances for in vivo clinical and laboratory research use; chemical reagents for scientific research use; chemicals used in science and medicine, namely, adjuvant compositions for use in the manufacture of vaccines and antibodies and antibody fragments for use in diagnostics and assays; cell lines for use in production of whole cell derived vaccines; cell lines for use in research related to virus mediated disease ]

Surgical apparatus for the treatment of varicose veins; medical syringes; cannula needles, medical tubing for administering drugs; surgical and medical apparatus for producing and administering pharmaceutical foams; surgical or medical apparatus for producing foams for treatment of varicose veins, arterio-venous malformations, oesophageal varices or hydroceles; devices for intravenous administration of pharmaceutical foam; diagnostic devices for grading the severity of venous conditions, snake envenomation and toxic drugs overdose

[ Product research and development, namely, development of pharmaceuticals and medical devices through preclinical and clinical research in the fields of envenomation, drug overdose, chemical poisoning, venous disease, autoimmune disease, pain and inflammation and cancer therapy ]
btg

General Information


Serial Number77858442
Word MarkBTG
Filing DateTuesday, October 27, 2009
Status800 - REGISTERED AND RENEWED
Status DateThursday, June 24, 2021
Registration Number3859364
Registration DateTuesday, October 12, 2010
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 27, 2010

Trademark Statements


Description of MarkThe mark consists of a circle with four lines inside of it; below the circle are the letters "BTG" in stylized lettering.
Goods and ServicesPharmaceutical and medicinal preparations and substances namely, vaccines and vaccine adjuvants, proteins, peptides, sera containing polyclonal antibodies and fragments thereof and polyclonal antibodies and fragments derived therefrom all for use in treating snake envenomation, overdose of toxic substances or sepsis; pharmaceutical preparations and substances for the treatment of thrombosis, [ inflammation, autoimmune disease and sleep disorders; dietetic foods adapted for medical use; ] vaccines; sera; polyclonal antibodies and fragments thereof for in vitro disease testing and for use in treating snake envenomation, overdose of toxic substances or sepsis; pharmaceutical preparations in the form of foams or for use in producing foams for use in sclerotherapy, phlebology, angiology and proctology, for treatment of oesophageal varices, hydroceles, in sterilisation treatment or for treatment of varicose veins or arteriovenous malformations; chemical reagents for medical or veterinary purposes; chemical reagents for therapeutic and diagnostic purposes, namely, for the treatment of and the diagnosis of the presence of toxic substances; pharmaceutical preparations for the treatment of cancer; [ pharmaceutical preparations for the reduction or elimination of circulating cytokines; pharmaceutical preparations for the treatment of neurodegeneration and multiple sclerosis; pharmaceutical preparations for the treatment of pain, including headache and migraine; ] pharmaceutical preparations for promoting the healing of dermal wounds and chronic wounds including ulcers and pressure sores; pharmaceutical and veterinary preparations for the treatment of digoxin, digitalis or other cardio-active glycoside toxicity; pharmaceutical preparations for the treatment of envenomation with snake venom; pharmaceutical preparations for treatment of excess levels of cancer agents; pharmaceutical preparations for the treatment of toxic levels of other pharmaceutical agents; pharmaceutical preparations for the treatment of cytotoxic cancer treatment drug overdose, particularly overdose with methotrexate; [ pharmaceutical preparations for the treatment of sleep apnea; pharmaceutical preparations for the treatment of head lice; ] diagnostic reagents for medical use and for the determination of levels of toxic substances in blood and tissue samples in vitro
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and Services[ Chemicals used in science; chemicals for clinical research use; diagnostic reagents and substances for clinical and medical laboratory use; diagnostic reagents and substances for clinical and medical laboratory in vitro research use; polyclonal antibodies and fragments thereof for clinical research use; diagnostic reagents and substances for in vivo clinical and laboratory research use; chemical reagents for scientific research use; chemicals used in science and medicine, namely, adjuvant compositions for use in the manufacture of vaccines and antibodies and antibody fragments for use in diagnostics and assays; cell lines for use in production of whole cell derived vaccines; cell lines for use in research related to virus mediated disease ]
Goods and ServicesSurgical apparatus for the treatment of varicose veins; medical syringes; cannula needles, medical tubing for administering drugs; surgical and medical apparatus for producing and administering pharmaceutical foams; surgical or medical apparatus for producing foams for treatment of varicose veins, arterio-venous malformations, oesophageal varices or hydroceles; devices for intravenous administration of pharmaceutical foam; diagnostic devices for grading the severity of venous conditions, snake envenomation and toxic drugs overdose
Goods and Services[ Product research and development, namely, development of pharmaceuticals and medical devices through preclinical and clinical research in the fields of envenomation, drug overdose, chemical poisoning, venous disease, autoimmune disease, pain and inflammation and cancer therapy ]

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status CodeB - Sec. 8 - Class(es) in a Multiple Class registration
Class Status DateFriday, April 21, 2017
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 30, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, October 30, 2009
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeB - Sec. 8 - Class(es) in a Multiple Class registration
Class Status DateFriday, April 21, 2017
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePROTHERICS MEDICINES DEVELOPMENT LIMITED
Party Type31 - New Owner After Registration
Legal Entity Type24 - NOT AVAILABLE
AddressLondon EC4V6JA
GB

Party NameBTG International Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressLondon EC4M7RD
GB

Party NameBTG International Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLondon EC4M7RD
GB

Party NameBTG International Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLondon EC4M7RD
GB

Trademark Events


Event DateEvent Description
Thursday, July 13, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 13, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 13, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, March 16, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, March 16, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 16, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 16, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, March 16, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 12, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, April 12, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 12, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, April 12, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 12, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 12, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, August 30, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, August 30, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 30, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 30, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 30, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, June 24, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, June 24, 2021REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, June 24, 2021REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, June 22, 2021TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Wednesday, June 9, 2021POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Wednesday, April 14, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, April 9, 2021TEAS SECTION 8 & 9 RECEIVED
Saturday, August 29, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Saturday, August 29, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, August 29, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, August 29, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, August 29, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, October 12, 2019COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, April 21, 2017NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Friday, April 21, 2017REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
Friday, April 21, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, April 5, 2017TEAS SECTION 8 RECEIVED
Wednesday, April 5, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 12, 2015COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, January 15, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 15, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 14, 2011TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 6, 2011TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 12, 2010REGISTERED-PRINCIPAL REGISTER
Tuesday, July 27, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 27, 2010PUBLISHED FOR OPPOSITION
Tuesday, June 22, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, June 21, 2010ASSIGNED TO LIE
Friday, June 4, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 28, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 28, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 28, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 26, 2010NOTIFICATION OF PRIORITY ACTION E-MAILED
Wednesday, May 26, 2010PRIORITY ACTION E-MAILED
Wednesday, May 26, 2010PRIORITY ACTION WRITTEN
Friday, May 7, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 7, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 7, 2010TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, April 21, 2010NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, April 21, 2010LETTER OF SUSPENSION E-MAILED
Wednesday, April 21, 2010SUSPENSION LETTER WRITTEN
Wednesday, March 31, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 31, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 31, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 1, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 1, 2010NON-FINAL ACTION E-MAILED
Monday, February 1, 2010NON-FINAL ACTION WRITTEN
Monday, February 1, 2010ASSIGNED TO EXAMINER
Saturday, October 31, 2009NOTICE OF DESIGN SEARCH CODE MAILED
Friday, October 30, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 30, 2009NEW APPLICATION ENTERED